The primary outcome of this study is to investigate whether deep NMB reversed with Sugammadex is superior to moderate NMB reversed with Neostigmine, in terms of overall pain in the first 48 hrs after laparoscopic gynecologic surgery, reversal time from NMB (TOF≥0.9) and direct and indirect costs. Additionally we will also assess: drugs consumption for pain and antiemetics (rescue dose), surgical conditions, hemodynamic and respiratory stability, operation time, anesthesia time, total amount and flow rate of CO2, insufflation time, resolution of post-operative ileus, dry mouth and PONV in the first 48 hours, patient satisfaction
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
100
Reversal of deep NMB
Reversal of moderate NMB
Campus Bio-medico
Roma, RM, Italy
Overall pain in the first 48 hrs after gynecologic surgical procedures
0 - 10 NRS scale of the overall pain in the first 48 hrs after gynecologic surgical procedures
Time frame: First 48 hrs after gynecologic surgical procedures
Recovery time (or Reversal time) from NMB (TOF≥0.9)
The recovery time (or Reversal time) will be measured in minutes from the administration of reversal agent to a TOF≥0.9
Time frame: The recovery time (or Reversal time) will be measured in minutes after the administration of reversal agent at the end of the surgical procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.